Erythema induratum of Bazin which occurred after tumor necrosis factor antagonist therapy.

Baba, Natsuki; Takashima, Wataru; Tokuriki, Atsushi; Ameshima, Shingo; Hasegawa, Minoru

Baba, Natsuki; Takashima, Wataru; Tokuriki, Atsushi; Ameshima, Shingo; Hasegawa, Minoru.

Afiliação

Baba N; Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Takashima W; Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Tokuriki A; Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Ameshima S; Department of Respiratory Medicine, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Hasegawa M; Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

J Dermatol ; 44(5): e87-e88, 2017 May.

Article em En | MEDLINE | ID: mdl-28106269

Assuntos

Antirreumáticos/efeitos adversos; Artrite Reumatoide/tratamento farmacológico; Certolizumab Pegol/efeitos adversos; Eritema Endurado/induzido quimicamente; Tuberculose dos Linfonodos/diagnóstico; Tuberculose dos Linfonodos/tratamento farmacológico; Idoso; Antituberculosos/uso terapêutico; Biópsia; Diagnóstico Diferencial; Quimioterapia Combinada; Etambutol; Feminino; Humanos; Perna (Membro); Reação em Cadeia da Polimerase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Tuberculose dos Linfonodos / Eritema Endurado / Antirreumáticos / Certolizumab Pegol Tipo de estudo: Diagnostic_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google